HOME › DRUGS › SECUKINUMAB
ACTIVE SUBSTANCE / INN

SECUKINUMAB

Brand name(s): Cosentyx, COSENTYX
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing
BLA761349
ACTIVE SUBSTANCE
Secukinumab
REGULATORS
FDA · EMA
SPONSORS / MAH
NOVARTIS PHARMS CORP, Novartis Europharm Limited
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
COSENTYXBLA761349NOVARTIS PHARMS CORPPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
CosentyxNovartis Europharm LimitedAuthorised14/01/2015Arthritis, Psoriatic;Psoriasis;Spondylitis, Ankylosing

FULL INTELLIGENCE ON SECUKINUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →